Paul Yarnold

6PUBLICATIONS
35CO-AUTHORS
Clinical pharmacology and therapeuticsPharmacogenomicsMedical infection agents (incl. prions)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 23, 2026
Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.

|Dec 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia.

Marta Zurawska, Adrian Valadez, Emma Harlan

|Dec 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia.

Ryan Williamson, Marta Zurawska, Adrian Valadez

|Nov 17, 2023
Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.

Roxane Rohani, Paul R Yarnold, Marc H Scheetz

|Dec 06, 2022
Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia.

Nathaniel J Rhodes, Roxane Rohani, Paul R Yarnold

|Mar 05, 2020
Fibromyalgia Impact Reduction Using Online Personal Health Informatics: Longitudinal Observational Study.

William Collinge, Robert Soltysik, Paul Yarnold

Pageof 1

Frequent Collaborators

5 joint publications

Nathaniel J Rhodes

4 joint publications

Richard G Wunderink

4 joint publications

Marc H Scheetz

4 joint publications

Michael N Neely